Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study.
Oncotarget(2022)
摘要
In this NSCLC cohort, tumor HA level represents a potential biomarker for TTP, which remains a cornerstone of NSCLC therapy. Further validation is warranted to identify the HA accumulation threshold associated with clinical benefit.
更多查看译文
关键词
biomarker,hyaluronan,hyaluronic acid,predictive,prognostic
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要